Skip to content

Clinical trials

Hematologic Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Country / region: Canada Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20071
20081
20098
20101
20114
20126
20132
20143
20155
20164
20173
20188
20193
20203
20219
20225
20234
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Active, not recruiting11
Recruiting9
Unknown status9
Terminated8
Enrolling by invitation2
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kiadis Pharma6
University Health Network, Toronto5
Bristol-Myers Squibb4
Children's Oncology Group4
Ciusss de L'Est de l'Île de Montréal4
National Cancer Institute (NCI)4
Ottawa Hospital Research Institute4
Merck Sharp & Dohme LLC3
Mount Sinai Hospital, Canada3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms80
Leukemia, Myeloid, Acute15
Multiple Myeloma14
Leukemia, Lymphocytic, Chronic, B-Cell12
Myelodysplastic Syndromes12
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Leukemia10
Lymphoma9
Neoplasms9
Lymphoma, Non-Hodgkin8

Trials

Showing 51 to 75 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.